Article

Single-cell molecular profiling using ex vivo functional readouts fuels precision oncology in glioblastoma

2022-10-19

Abstract excerpt

<h4>Background</h4> Functional profiling of freshly isolated glioblastoma cells is being evaluated as a next-generation method for precision oncology. While promising, its success largely depends on the method to evaluate treatment activity which requires sufficient resolution and specificity. <h4>Methods</h4> Here, we describe the ‘ pr ecision o ncology by s ingle-cell p rofiling using e x vivo readouts o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 20f41b88-f9e2-5710-adae-1987e3fef726
DOI: 10.1101/2022.10.17.512525

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Single-cell molecular profiling using ex vivo functional readouts fuels precision oncology in glioblastomaDOI 10.1101/2022.10.17.512525Read

Single-cell molecular profiling using ex vivo functional readouts fuels precision oncology in glioblastomaSemantic proximity Read

Gliamimic: A Longitudinal, Multimodal in Vitro Platform for Evaluating Glioblastoma Treatment Response and Relapse in Patient-derived Organoids or SpheroidsSemantic proximity Read

Functional Precision Oncology: The Next Frontier to Improve Glioblastoma Outcome?Semantic proximity Read

Functional drug susceptibility testing using single-cell mass predicts treatment outcome in patient-derived cancer neurosphere modelsSemantic proximity Read

Metabolic-imaging of human glioblastoma live tumors: a new precision-medicine approach to predict tumor treatment response earlySemantic proximity Read

A Patient-Derived Cell Atlas Informs Precision Targeting of Glioblastoma.Semantic proximity Read

Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkersSemantic proximity Read

Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patientsSemantic proximity Read

Rapid Functional Drug Screening of Passage-Zero Patient Brain Tumor Tissues Ex Vivo: Results from a Clinical Feasibility StudySemantic proximity Read

Quantitative single cell heterogeneity profiling of patient derived tumor initiating gliomaspheres reveals unique signatures of drug response and malignancySemantic proximity Read

Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivitySemantic proximity Read

Patient-derived tumor organoids mimic treatment-induced DNA damage response in glioblastomaSemantic proximity Read